A Pilot Study of Intralesional Injection of Triamcinolone Acetonide for Desmoid Tumors
Status:
Active, not recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
There is research supporting treatment of superficial fibromatoses (palmar fibromatosis and
keloids) with triamcinolone acetonide injections. These lesions are histologically similar to
deep fibromatoses (desmoid tumors). Currently there is little literature evaluating the
response of desmoid tumors to injections of triamcinolone acetonide. The investigators aim to
perform a pilot study evaluating the response of desmoid tumors to intralesional
triamcinolone. If positive results are observed (based on RECIST criteria), then a phase II
study will be initiated.